// App-Quantinova.ai

2989 : Direct Oral Anticoagulants for Myeloproliferative Neoplasms (MPN-DOACs): Results from an International Study on 442 Patients

Researchers

Presenter

  • Tiziano Barbui

Principal Investigators

  • Alessandra Carobbio

  • Alessandra Iurlo

  • Alberto Alvarez-Larran

  • Alessandro Vannucchi

  • Francesca Palandri

  • Claire Harrison

  • Hassan Sibai

  • Martin Griesshammer

  • Massimiliano Bonifacio

  • Elena M Elli

  • Chiara Trotti

  • Steffen Koschmieder

  • Giuseppe Carli

  • Giulia Benevolo

  • Jean-Christophe Ianotto

  • Swati Goel

  • Anna Falanga

  • Silvia Betti

  • Daniele Cattaneo

  • Eduardo Arellano-Rodrigo

  • Lara Mannelli

  • Nicola Vianelli

  • Andrew Doyle

  • Vikas Gupta

  • Kai Wille

  • Douglas Tremblay

  • John Mascarenhas

Medical Centers

  • FROM Research Foundation,ASST Papa Giovanni XXIII,Bergamo, Italy,Italy

  • Hematology Department, Fondazione Policlinico Universitario A. Gemelli, Universit Cattolica del Sacro Cuore, Rome, Italy

  • FROM Research Foundation,ASST Papa Giovanni XXIII,Bergamo, Italy,Italy

  • Oncohematology Division, Fondazione IRCCS Ospedale Maggiore Policlinico, Milan, Italy

  • Servicio de Onco-Hematologia,Hospital Clinica de Barcelona,Barcelona,Spain

  • CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

  • Institute of Hematology “L. and A. Seràgnoli”, Sant’Orsola-Malpighi University Hospital,Bologna,Italy

  • Department of Haematology, Guys and St Thomas Hospitals NHS Trust, London, United Kingdom

  • Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

  • Universitiy Clinic for Hematology, Oncology, Hemostaseology and Palliative Care,Johannes Wesling Medical Center Minden,Minden,Germany

  • Department of Medicine, Section of Hematology, University of Verona, Verona, Italy

  • Azienda Ospedaliera Universitaria Integrata, Policlinico G. Rossi, Verona, Italy

  • Hematology, San Gerardo Hospital, MONZA, Italy

  • Department of Clinical Medicine 3, University of Padova, Padova, Italy

  • Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, RWTH Aachen University Hospital, Aachen, Germany

  • Hematology, Ospedale S. Bortolo, Vicenza, Italy

  • A.O.U. Citta della Salute e della Scienza di Torino, Torino, Italy

  • Clinical Hematology, Institut de Cancéro-Hématologie, Brest University Hospital, Brest, France

  • Div of Hematology, Dept of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY

  • Immunohematology and Transfusion Medicine Division, ASST Papa Giovanni XXIII, Bergamo, Italy

  • Policlinico Universitario “A. Gemelli” IRCCS, Catholic University, Roma, Italy

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Center for Research and Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, University of Florence, Florence, Italy

  • Institute of Hematology "L. & A. Seragnoli", Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italy

  • Department of Medical Oncology, Guys and St Thomas NHS Foundation Trust, London, United Kingdom

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Johannes Wesling Medical Center, University of Bochum, Bochum, Germany

  • The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

Locations

  • Italy

  • Spain

  • United Kingdom

  • Canada

  • Germany

  • France

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myeloid neoplasms

  • Essential thrombocythemia

  • Venous thrombosis

  • Arrhythmia

  • Polycythemia vera

  • Thrombocytopenia

  • Myelofibrosis

  • Hypertension

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

  • rivaroxaban

  • Pradax

  • apixaban

  • Edoxaban

Outcome

  • N/A

Study Design

  • Randomized

  • Multinational

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved